{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T14:08:48Z","timestamp":1780841328271,"version":"3.54.1"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T00:00:00Z","timestamp":1734048000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Jiangsu Pharmaceutical Association-HengRui Hospital Pharmacy Fund"},{"name":"Nantong First People's Hospital High-level Science and Technology Project Cultivation Fund","award":["(No.YPYJJZD007)"],"award-info":[{"award-number":["(No.YPYJJZD007)"]}]},{"name":"Fund of drug policy and pharmaceutical care of Nantong City","award":["(No.2023NTPA05)."],"award-info":[{"award-number":["(No.2023NTPA05)."]}]},{"name":"Fund of Nantong university","award":["(No.2022JZ005)"],"award-info":[{"award-number":["(No.2022JZ005)"]}]},{"name":"Fund of Nantong university","award":["(No2022JY004)"],"award-info":[{"award-number":["(No2022JY004)"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,12,13]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Acute pancreatitis (AP) is a common pancreatic disease. Xuebijing injection (XBJ) combined with somatostatin in the treatment of AP is frequently used in clinical practice. There is, however, a lack of high-quality evidence-based evidence and network pharmacology to regard the therapeutic efficacy and pharmacological mechanisms.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>The purpose of this study is to investigate the potential therapeutic targets and pharmacological mechanism of XBJ in AP using integrating evidence-based medicine and network pharmacology.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>PubMed, Embase, Cochrane Library, China National Knowledge Infrastructure, Weipu, and Wanfang databases were searched. Randomized controlled trials of XBJ combined with somatostatin (experimental group) versus somatostatin alone (control group) in the treatment of AP were collected. After extracting data from the literature that meets the inclusion criteria, and using the Cochrane Scale to evaluate the quality of the literature, we used Rev Man 5.3.0 statistical software to perform meta-analysis of the effective rate, the disappearance time of abdominal pain and bloating, the recovery of gastrointestinal motility, serum-related indicators, inflammatory factors, ventilator evacuation time, and hospitalization time. A network pharmacology is used to analyze the potential active ingredients and related crucial targets of the XBJ in the treatment of AP, and we explored key regulatory pathways and potential biomarkers related to XBJ for AP with integrated bioinformatics analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>It was significant that the total effective rate in the study group was higher than that in the control group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). The time of recovery of gastrointestinal motility, serum-related indicators, inflammatory factors, ventilator withdrawal time, and hospitalization time were significantly lower than that of the control group. The differences were statistically significant (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05). Signal transducer and activator of transcription 3, tumor protein P53, interleukin 6, tumor necrosis factor, Jun Proto-Oncogene, SRC Proto-Oncogene, Heat Shock Protein 90 Alpha Family Class A Member 1, Vascular Endothelial Growth Factor A, Epidermal Growth Factor Receptor, and Mitogen-Activated Protein Kinase 1 were identified as the key hub of the protein\u2013protein interaction network according to an analysis of network centrality. According to the Kyoto Encyclopedia of Genes and Genomes pathway analysis, the main pathways are involved in PI3K\u2013Akt signaling pathway, HIF-1 signaling pathway, and tumor necrosis factor signaling pathway.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>The effectiveness of combination therapy of XBJ and somatostatin on AP is likely to be better than somatostatin. In addition, XBJ and somatostatin synergistically treated AP through a multi-pathway network.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000040964","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T19:03:54Z","timestamp":1734375834000},"page":"e40964","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Xuebijing and somatostatin against acute pancreatitis: A systematic review and network pharmacology"],"prefix":"10.1097","volume":"103","author":[{"given":"Ji-Ping","family":"Cao","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Affiliated Hospital 2 of Nantong University, And First People\u2019s Hospital of Nantong City, Nantong, Jiangsu Province, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Hua","family":"Piao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Jiangwan Hospital of Shanghai Hongkou District, Shanghai, P.R. China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long-Xun","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Affiliated Hospital 2 of Nantong University, And First People\u2019s Hospital of Nantong City, Nantong, Jiangsu Province, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7817-7971","authenticated-orcid":false,"given":"Pan-Feng","family":"Feng","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Affiliated Hospital 2 of Nantong University, And First People\u2019s Hospital of Nantong City, Nantong, Jiangsu Province, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250503","first-page":"438","article-title":"Mortality in acute pancreatitis: is it an early or a late event?","volume":"6","author":"Carnovale","year":"2005","journal-title":"JOP"},{"key":"R2-20250503","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41575-018-0087-5","article-title":"Global epidemiology and holistic prevention of pancreatitis.","volume":"16","author":"Petrov","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R3-20250503","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/j.gastro.2018.08.063","article-title":"Burden and cost of gastrointestinal, liver, and pancreatic diseases in the united states: update 2018.","volume":"156","author":"Peery","year":"2019","journal-title":"Gastroenterology"},{"key":"R4-20250503","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMra1505202","article-title":"Acute pancreatitis.","volume":"375","author":"Forsmark","year":"2016","journal-title":"N Engl J Med"},{"key":"R5-20250503","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1136\/gutjnl-2012-302779","article-title":"Classification of acute pancreatitis \u2013 2012: revision of the Atlanta classification and definitions by international consensus.","volume":"62","author":"Banks","year":"2013","journal-title":"Gut"},{"key":"R6-20250503","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/MPA.0000000000001260","article-title":"Serum serine peptidase inhibitor Kazal-type 1, trypsinogens 1 to 3, and complex of trypsin 2 and \u03b11-antitrypsin in the diagnosis of severe acute pancreatitis.","volume":"48","author":"Rainio","year":"2019","journal-title":"Pancreas"},{"key":"R7-20250503","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1113\/JP277856","article-title":"The Orai Ca2+ channel inhibitor CM4620 targets both parenchymal and immune cells to reduce inflammation in experimental acute pancreatitis.","volume":"597","author":"Waldron","year":"2019","journal-title":"J Physiol"},{"key":"R8-20250503","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jep.2016.09.053","article-title":"Add-on effect of crude rhubarb to somatostatin for acute pancreatitis: a meta-analysis of randomized controlled trials.","volume":"194","author":"Zhou","year":"2016","journal-title":"J Ethnopharmacol"},{"key":"R9-20250503","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ajem.2021.07.004","article-title":"Effect of Guo Qing Yi Tang combined with Western medicine cluster therapy on acute pancreatitis.","volume":"50","author":"Chen","year":"2021","journal-title":"Am J Emerg Med"},{"key":"R10-20250503","doi-asserted-by":"crossref","first-page":"883729","DOI":"10.3389\/fphar.2022.883729","article-title":"Chinese herbal medicine xuebijing injection for acute pancreatitis: an overview of systematic reviews.","volume":"13","author":"Zhu","year":"2022","journal-title":"Front Pharmacol"},{"key":"R11-20250503","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jpba.2017.01.024","article-title":"Rapid determination of 30 bioactive constituents in XueBiJing injection using ultra high performance liquid chromatography-high resolution hybrid quadrupole-orbit rap mass spectrometry coupled with principal component analysis.","volume":"137","author":"Zuo","year":"2017","journal-title":"J Pharm Biomed Anal"},{"key":"R12-20250503","first-page":"24","article-title":"Effect of Xuebijing injection combined with somatostatin on inflammatory factors and adverse reactions in patients with acute pancreatitis.","volume":"19","author":"Cui","year":"2022","journal-title":"Health Med Res Prac"},{"key":"R13-20250503","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.phymed.2018.09.018","article-title":"Exploring pharmacological mechanisms of Xueshuan-Xinmai-Ning tablets acting on coronary heart disease based on drug target-disease gene interaction network.","volume":"54","author":"Mao","year":"2019","journal-title":"Phytomedicine"},{"key":"R14-20250503","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred reporting items for a systematic review and meta-analysis of individual participant data: the PRISMAIPD statement.","volume":"313","author":"Stewart","year":"2015","journal-title":"JAMA"},{"key":"R15-20250503","first-page":"730","article-title":"Study on the mechanism of Xuebijing injection in the treatment of novel coronavirus pneumonia based on network pharmacology.","volume":"22","author":"Kong","year":"2020","journal-title":"World Sci Technol"},{"key":"R16-20250503","first-page":"6621368","article-title":"Efficacy of Xuebijing injection for acute pancreatitis: a systematic review and meta-analysis of randomized controlled trials.","volume":"2021","author":"Chen","year":"2021","journal-title":"Evid Based Complement Alternat Med"},{"key":"R17-20250503","first-page":"241","article-title":"Network pharmacology and drug discovery.","volume":"42","author":"Wang","year":"2011","journal-title":"Prog Physiol Sci"},{"key":"R18-20250503","first-page":"104","article-title":"Research progress on pharmacological effects of quercetin.","volume":"13","author":"Liu","year":"2020","journal-title":"Chin J Lung Dis (Electron Ed)"},{"key":"R19-20250503","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.3892\/mmr.2016.5351","article-title":"Paeoniflorin ameliorates acute necrotizing pancreatitis and pancreatitis-induced acute renal injury.","volume":"14","author":"Wang","year":"2016","journal-title":"Mol Med Rep"},{"key":"R20-20250503","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1142\/S0192415X15500640","article-title":"Rosmarinic acid attenuates sodium taurocholate-induced acute pancreatitis in rats by inhibiting nuclear factor-\u03baB activation.","volume":"43","author":"Fan","year":"2015","journal-title":"Am J Chin Med"},{"key":"R21-20250503","first-page":"273","article-title":"The protective effect of luteolin on the pancreas of mice with severe acute pancreatitis and the possible molecular mechanism.","volume":"51","author":"Wang","year":"2020","journal-title":"Acta Anat Sin"},{"key":"R22-20250503","first-page":"558","article-title":"STAT3 signaling in pathogenesis of pancreatitis.","volume":"32","author":"Zong","year":"2016","journal-title":"Chin J Pathol"},{"key":"R23-20250503","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/MPA.0000000000000707","article-title":"Genetic susceptibility in acute pancreatitis: genotyping of GSTM1, GSTT1, GSTP1, CASP7, CASP8, CASP9, CASP10, LTA, TNFRSF1B, and TP53 gene variants.","volume":"46","author":"D\u2019Oliveira Martins","year":"2017","journal-title":"Pancreas"},{"key":"R24-20250503","first-page":"1099","article-title":"Nuclear TP53: an unraveled function as transcriptional repressor of PINK1.","volume":"14","author":"Checler","year":"2018","journal-title":"Autophagy"},{"key":"R25-20250503","first-page":"3074","article-title":"The role of PI3K-AKT signaling pathway in pathogenesis and progress of acute pancreatitis.","volume":"17","author":"Xu","year":"2011","journal-title":"Med Recapitulate"},{"key":"R26-20250503","first-page":"330","article-title":"PI3K\/Akt\/mTOR signaling pathway involved in the regulation of the expression of hypoxia inducible factor-1\u03b1 in rats with acute pancreatitis.","volume":"30","author":"Cheng","year":"2010","journal-title":"Chin J Crit Care Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040964","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T00:38:13Z","timestamp":1746319093000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000040964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,13]]},"references-count":26,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000040964","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,13]]}}}